Myeloid neoplasms with der(1)t(1;19) may constitute a specific entity characterized by a cytogenetic biomarker and gene mutations involved in DNA methylation

MLA

Francesco Acquadro, et al. “Myeloid Neoplasms with Der(1)t(1;19) May Constitute a Specific Entity Characterized by a Cytogenetic Biomarker and Gene Mutations Involved in DNA Methylation.” Leukemia & Lymphoma, vol. 55, Mar. 2014, pp. 2652–55. EBSCOhost, https://doi.org/10.3109/10428194.2014.891024.

APA

Francesco Acquadro, Javier Suela, Carolina Martínez-Laperche, Mercedes Trujillo, Juan C. Cigudosa, Rafael Flores, Sara Alvarez, María Calvente, Juliane Menezes, & Rocío Salgado. (2014). Myeloid neoplasms with der(1)t(1;19) may constitute a specific entity characterized by a cytogenetic biomarker and gene mutations involved in DNA methylation. Leukemia & Lymphoma, 55, 2652–2655. https://doi.org/10.3109/10428194.2014.891024

Chicago

Francesco Acquadro, Javier Suela, Carolina Martínez-Laperche, Mercedes Trujillo, Juan C. Cigudosa, Rafael Flores, Sara Alvarez, María Calvente, Juliane Menezes, and Rocío Salgado. 2014. “Myeloid Neoplasms with Der(1)t(1;19) May Constitute a Specific Entity Characterized by a Cytogenetic Biomarker and Gene Mutations Involved in DNA Methylation.” Leukemia & Lymphoma 55 (March): 2652–55. doi:10.3109/10428194.2014.891024.